# Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

> **NCT01770132** · PHASE1 · COMPLETED · sponsor: **John DeWitt** · enrollment: 12 (estimated)

## Conditions studied

- Acinar Cell Adenocarcinoma of the Pancreas
- Duct Cell Adenocarcinoma of the Pancreas
- Stage III Pancreatic Cancer

## Interventions

- **DRUG:** porfimer sodium
- **PROCEDURE:** endoscopic ultrasonography
- **PROCEDURE:** photodynamic therapy
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT01770132
- **Lead sponsor:** John DeWitt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-19
- **Primary completion:** 2017-07-13
- **Final completion:** 2018-10-28
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-12-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01770132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01770132, "Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01770132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*